Ambiguous results such as high anti-tTG IgA antibody titers without villous atrophy (potential CD) or lack of anti-tTG antibodies in patients with villous atrophy (seronegative CD, SnCD) can hamper prompt diagnosis and treatment. The gene discussed is CD79A; the disease is Cowden disease.